| Market Cap | ₹272Cr |
| ROE | 11.59% |
| P/E Ratio(TTM) | 28.19 |
| EPS(TTM) | 4.08 |
| P/B Ratio | 2.98 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.79 |
| Book Value | 38.56 |
| Debt to Equity | 0.36 |
| Face Value | 10 |
| Managing Director | Bafna Mahaveer Chand |
| Founded | 1995 |
| NSE Symbol | BAFNAPH |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 64.23 | ||
| Ajanta Pharma | NA (0.00%) | 36.67 | ||
| Gland Pharma | NA (0.00%) | 35.05 | ||
| Sai Life Sciences | NA (0.00%) | 61.53 |